Research Article
CMIP Promotes Proliferation and Metastasis in Human Glioma
Table 2
Association of CMIP expression with clinicopathological parameters from glioma patients.
| Parameter | | CMIP expression ( (%)) | | Low | High |
| Age (years) | | <50 | 62 | 38 (61.3) | 24 (38.7) | 0.931 | ≥50 | 37 | 23 (62.2) | 14 (37.8) | Gender | | Female | 41 | 29 (70.7) | 12 (29.3) | 0.117 | Male | 58 | 32 (55.2) | 26 (44.8) | KPS | | <80 | 35 | 20 (57.1) | 15 (42.9) | 0.499 | ≥80 | 64 | 41 (64.1) | 23 (35.9) | Grade | | I-II | 48 | 38 (79.2) | 10 (20.8) | 0.001 | III-IV | 51 | 23 (45.1) | 28 (54.9) |
|
|
Note. KPS (Karnofsky performance score).
|